ethyl-10-hydroxy-camptothecin (SN-38) were purchased from Tokyo Chemical Industry Co.,
Ltd., Santa Cruz Biotechnology, Inc. and AK Scientific, Inc., respectively. Histamine dihydrochloride (ceplene), amikacin hydrate, quabain octahydrate, erythromycin, epinephrine, dopamine hydrochloride, azithromycin, digitoxin, roxithromycin, L-glutathione reduced, S-hexylglutathione, salicylic acid, 4-formyl benzoic acid, hexamethylenediamine, 1,2-diaminoethane and 9-chloro-1,2,3,4-tetrahydroacridine were obtained from SigmaAldrich. Aluminum-backed silica plates (Merck silica gel 60 F254) were used for thin layer chromatography (TLC) to monitor solution-phase reactions. TLC visualization was carried out using short wavelength ultraviolet (UV) light at 254 nm. The 1 H NMR spectra were recorded using 300 MHz, 400 MHz or 500 MHz Bruker Avance NMR spectrometer. The 13 C NMR spectra were recorded using a 400 MHz Bruker Avance NMR spectrometer. Chemical shifts are reported in ppm on the δ scale down field from TMS as the internal standard. The following abbreviations were used to describe the peaks: s-singlet, d-doublet, dd-double doublet, t-triplet, q-quartet, quin-quintet, m-multiplet, and br-broad. Electronspray mass spectrometry was performed with a Micromass Platform LCZ-4000 instrument at the Weizmann Institute of Science mass spectrometry facility. Preparative HPLC purifications were done on a Thermo Separation instrument (P200 pump, UV 100 detector) and a prepacked Vydac C 18 column. Analytical purity of TOPIs 1-6 was confirmed by an Agilent 1260 infinity quaternary pump LC system, maximum pressure 400 bar, equipped with a diode-
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array detector with max-light high-sensitivity cartridge cell. Analysis was performed using 0.1% TFA water/acetontitrile as eluent and detecting the absorbance at 220 and 480 nm (section 8). The absorption and excitation spectra of TOPIs 1-6 in DMSO were acquired using a BioTek synergy H4 hybrid multiwell plate reader (Fig. S9) 
Synthesis of TOPI-3 and TOPI-4.
3-iodo-1-propanol (C 12 ) was prepared according to a published procedure. 
1-(3-hydroxypropyl)quinolin-1-ium iodide (C 14 )
. 3-iodo-1-propanol (2.45 mL, 25.5 mmol) was added to a solution of quinoline (1.01 mL, 8.5 mmol) in 9 mL of dioxane and the solution was stirred under reflux for 2.5 h. After cooling to room temperature, the product was precipitated by addition of acetone (6 mL). The residue was separated by filtration and then washed with acetone to yield a yellow solid compound (2.1 g, 80%). 188.10; found 188.03. 
3-(3-hydroxypropyl)-2-((1-(3-hydroxypropyl)quinolin-4(1H) ylidene) methyl) benzo thiazol-3-ium iodide (C 15

3-(3-((prop-2-yn-1-ylcarbamoyl)oxy)propyl)-2-((1-(3-((prop-2-yn-1-ylcarbamoyl) oxy) propyl)quinolin-4(1H)-ylidene)methyl)benzothiazol-3-ium iodide (C 17 ).
N,N'-carbonyldiimidazole (CDI) (0.343 g, 2.11 mmol) and 4-Dimethylaminopyridine (4-DMAP) (0.00035 g, 2.88 ×10 -3 mmol) were added to a solution of C 15 (0.5 g, 0.96 mmol) in dry DMF (4.6 mL) and dry DCM (1 mL). The reaction mixture was stirred at room temperature for 4 h. Then, triethylamine (402 µL, 2.88 mmol) was added, the reaction mixture was cooled to 0 °C, and propargylamine (135.4 µL, 2.11 mmol) was added dropwise. The mixture was stirred at room temperature for 48 h and monitored by TLC (10% DCM:MeOH) and HPLC. The reaction mixture was evaporated and purified by column chromatography (7-10% MeOH:DCM) to yield a dark red solid material (0.22 g, 33% 
Inhibition and Dissociation Constants
GST Kinetic Measurements and Inhibitory Constants
Inhibition of GST-A1-1, GST-M1-1, GST P1-1, and GST-A2-2 activity by TOPI-3 and TOPI-4 was tested using a method developed by Habig et al. 3 ( Fig. 5 and S5) . The concentrations of different GSTs, GSH, and CDNB were 20 nM, 350 µM, and 700 µM, respectively. The GST activity was measured spectrophotometrically using chloro-2,4-dinitrobenzene (CDNB) and GSH as substrates, in phosphate buffer (10 mM, pH 6.5). In a typical experiment, GST and TOPI-3 or TOPI-4 were incubated for 10 min at 25°C and then GSH and CDNB were subsequently added. The formation of S-(2,4-dinitrophenyl)-glutathione was monitored using the microplate reader at λ = 340 nm. In order to obtain the inhibition constant, we performed the enzymatic assays using three different Where Y is the enzyme activity, X is different concentrations of inhibitor (TOPI-3 or TOPI-4), E is the enzyme concentration, S is the concentration of substrate, K m is the Michaelis-Menten constant determined in an experiment without inhibitor, and V 0 is the initial velocity. The inhibition constant obtained for GST isoforms (GST M1-1, GST P1-1, GST A1-1, and GST A2-2) are listed in Table S1 for TOPI-3.
S16
Dissociation Constants
The approximate dissociation constants were determined for GST-M1-1 and GST-P1-1.
For these experiments, the concentration of the probe was chosen according to the enzymatic assays (K i values, Fig. S4 ). It was chosen to be lower than the K i (expected GST-M1-1 and the TOPI-4-GST-P1-1 interaction were found to be 16.4 ± 2.14 nM (R 2 =0.99), and 28.97 ± 5.21 nM (R 2 =0.98), respectively.
AChE Kinetic Measurements and Inhibitory Constants
Inhibition of AChE activity by TOPI-1 and TOPI-2 was tested according to a published method by Ellman et al. 5 The AChE activity was measured spectrophotometrically using 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) and acetylthiocholine iodide as substrates, in phosphate buffer (50 mM, pH 8.0). In a typical experiment, AChE and TOPI-1 (50 nM) or TOPI-2 (2 µM) were incubated for 10 min at 25°C and then DTNB and acetylthiocholine iodide were subsequently added. The final concentrations of AChE, DTNB, and acetylthiocholine iodide were 8 pM, 0.4 mM, and 0.4 mM, respectively. The AChE activity was monitored using a microplate reader at λ = 410 nm (Fig. 5) . TOPI-1 demonstrated full inhibition at low nanomolar concentration, while TOPI-2 inhibited the AChE activity only at 2 µM. For the control assays, the activity of AChE was evaluated using 50 nM of 9-chloro-1,2,3,4-tetrahydroacridine (tacrine), a known AChE inhibitor, S17 and using a 10-fold excess (5 µM) of a control TO derivative C 6 
Fluorescence Measurements
GST Sensing
Based on the obtained binding constants (Fig. S3) , a concentration of 100 nM probe was chosen for GST sensing. This concentration should ensure strong binding and a high S/N ratio. The fluorescence intensity of TOPI-3 or TOPI-4 (100 nM) in phosphate buffer (5 mM, pH=6.5) was recorded before and after the addition of 90 nM of different GST isoforms (GST A1-1, GST A2-2, GST P1-1, GST M1-1, GST O1-1, GST K1-1, GST Z1-1, and GST T1-1) using a microplate reader and an excitation wavelength of 500 nm. For TOPI-3, fluorescence values were recorded immediately after addition of the GSTs (Fig.   3b and 4c) . The emission of TOPI-4 was recorded after 30 min incubation ( Fig. 3c and   4c ).
GST M1-1 Sensing in the Presence of Other GST Isoforms
We tested the ability of TOPI-3 to selectively bind to GST M1-1 in the presence of all other GST isoforms. Two different mixtures of GST isoforms were prepared: one that contained all the GST isoforms (20 nM of each GST, in total 160 nM) (A1-1, A2-2, P1-1, M1-1, T1-1, O1-1, Z1-1, and K1-1) and the second mixture contained all the GST isoforms except GST-M1-1. The fluorescence of TOPI-3 (100 nM) in phosphate buffer (5 mM, pH=6.5) was recorded before and after the addition of each GST mixture (Fig. 10a) .
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Screening Assay with Different Known Drugs
Fluorescence intensities were recorded before and after the addition of known GST inhibitors or randomly selected drugs (50 µM) to a mixture containing TOPI-3 and GST M1-1 (90 nM each) (Fig. 8) .
Av and SAv Sensing
The fluorescence intensity of TOPI-5 (100 nM) or TOPI-6 (100 nM) in phosphate buffer (15 mM, pH=7.3) was recorded before and after the addition of 90 nM Av or SAv using a microplate reader. Excitation wavelengths for TOPI-5 and TOPI-6 were 495 nm and 505 nm, respectively. Fluorescence values were recorded immediately after addition of the proteins ( Fig. 3d and 4b ).
AChE Sensing
The fluorescence intensity of TOPI-1 (100 nM) or TOPI-2 (100 nM) in a phosphate buffer (20 mM, pH=8) was recorded before and after the addition of 90 nM AChE using a microplate reader. Excitation wavelengths for TOPI-1 and TOPI-2 were 505 nm and 510 nm, respectively. Fluorescence values were recorded immediately after addition of the proteins (Fig. 3a and 4a ).
Control Experiments
For the control experiments with serum proteins (Fig. 6) , 2µM of lysozyme, PDGF-BB, IgA, IgG, FGF-21, fibrinogen, and transferrin and 1µM of HSA were used. In the control experiments with dsDNA (Fig. 7e) , two complementary ODNs (oligo A and oligo T, 20 bp) were incubated at 95°C for five minutes and then annealed at room temperature for 30 minutes. Fluorescence intensities of TO (100 nM) or TOPI-1, TOPI-3, TOPI-4 and TOPI-5 (100 nM) were recorded before and after the addition of a dsDNA (400 nM) in phosphate buffer (5 mM, pH=6.5) at λ ex = 500 nm.
General Procedure for Fluorescence Titration
TOPI-1, TOPI-3, TOPI-4, and TOPI-5 were excited at 500 ± 5 nm and the emission spectra were collected (Fig. S2) . Increasing concentrations of the corresponding target S19 proteins (20 nM, 40 nM, 60 nM, 90 nM, and 120 nM) were added and the emission spectra were recorded again. As shown in Fig. S2 , incremental addition of the target proteins has led to gradual increase in the fluorescence intensity of each of the TOPI probes, while the overall spectral shape remained intact.
GST Sensing in Urine Samples
Fresh urine samples were desalted by ultrafiltration using 3-kDa cutoff Centricon Plus-70 filters (Millipore, MA) according to manufacturer's procedure. Then GST-P1-1 (60 µg), GST M1-1 (54 µg) or combination of both were added to 150 µL of desalted urine samples and each urine sample was incubated with 50 µL of pre-washed Glutathione Sepharose™ affinity beads (GE Healthcare, UK) and gently agitated by end-over-end rotation at room temperature for 1 h. After separation of supernatant from the beads, the beads were washed with phosphate binding buffer (10 mM, pH 7.3 containing 140 mM NaCl, 2.7 mM KCl, and 1 mM dithiothreitol) to remove the non-specifically bound proteins. GSTs were then eluted from the beads using 100 µL of 10 mM reduced Lglutathione in Tris-HCl buffer (50 mM, pH = 8) and collected by centrifuging (500 × g, 1 min). Finally, the excess of GSH was removed by ultrafiltration using 3 kDa cutoff centrifugal filters (Amicon Ultra, Millipore). . Cell images were analyzed using imageJ. Tables   Table S1 . Approximate inhibition constants of different GST isoforms by TOPI-3. The GSH and CDNB concentrations were 3 mM and 1.5 mM, respectively. 
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